✨ Free AI Report
Haw Par Corporation Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Haw Par Corporation Limited
Company Research

Haw Par Corporation Limited: Business Overview, Financials & Competitive Analysis

Haw Par Corporation Limited scores 7/10 on the AskCyborg Cyborg Score (Strong). Haw Par is a cash-generative conglomerate with iconic consumer brands, strong balance sheet, and diversified revenue streams offering stability and dividend potential. The company maintains excellent financial strength with a current ratio of 6.21 and minimal debt (0.01 debt-to-equity). Stock price has increased 31.79% over the past 52.

What is Haw Par Corporation Limited's industry? Haw Par Corporation Limited (hawpar.com) operates in Consumer Healthcare / Pharmaceuticals. AskCyborg classifies Haw Par Corporation Limited under Consumer Healthcare / Pharmaceuticals in its company registry.

Haw Par manufactures, markets, and trades healthcare products across Singapore, ASEAN countries, and international markets. The group's largest contributor is Tiger Balm, arguably the world's leading topical analgesic...

7/ 10Strong

Cyborg Score thesis

Haw Par is a cash-generative conglomerate with iconic consumer brands, strong balance sheet, and diversified revenue streams...

Read the full analyst-debate transcript →
Industry Consumer Healthcare / Pharmaceuticals
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Haw Par Corporation Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Haw Par Corporation Limited

AskCyborg analysts argue the bull and bear cases for Haw Par Corporation Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Haw Par Corporation Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Haw Par Corporation Limited Overview

Pro stress-test →

Haw Par manufactures, markets, and trades healthcare products across Singapore, ASEAN countries, and international markets. The group's largest contributor is Tiger Balm, arguably the world's leading topical analgesic brand available in over 100 countries.

Strategic Profile

Pro stress-test →

Haw Par is a strong consumer healthcare business promoting healthy lifestyles through its healthcare products. Beyond healthcare, the company engages in long-term securities investing, property leasing, and leisure activities including oceanariums.

Competitive Landscape

Pro stress-test →

Haw Par dominates the topical analgesic category through Tiger Balm's century-old brand equity and global distribution. Competitors in the broader pain relief market include international pharmaceutical brands and regional OTC producers, though Tiger Balm's penetration and brand loyalty remain significant competitive advantages.

Industry Context

Haw Par Corporation Limited operates in Consumer Healthcare / Pharmaceuticals.

Key facts

Founded: 1969 · Headquarters: Singapore, Singapore · Revenue: $253.05M SGD · Market cap: $2.77B SGD

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Haw Par Corporation Limited.

  • Tiger Balm brand operates in 100+ countries as a leading topical analgesic with global recognition and distribution reach
  • Strong financial position: SGD 699.51M cash, minimal debt, and 2.34% dividend yield with disciplined capital allocation
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026Stock traded near all-time high of 17.25 SGD with continued positive momentum
  • Dec 2025Earnings showed strong performance with SGD 144.14M net income in latest half-year
  • +1 moreTrack every material event for Haw Par Corporation Limited as it happens. Explore monitoring →
Get alerted when Haw Par Corporation Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Pain Relief ProductsGlobal OTC pain management solutions→Regional Topical AnalgesicsRegional competitors in topical pain relief→

Compare Haw Par Corporation Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Haw Par Corporation Limited operates in Consumer Healthcare / Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Consumer Healthcare / Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Haw Par Corporation Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Haw Par Corporation Limited and its top competitor on Cyborg Score”
“What did Haw Par Corporation Limited do this quarter?”
“Is Haw Par Corporation Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Haw Par Corporation Limited do?+
Haw Par manufactures, markets, and trades healthcare products across Singapore, ASEAN countries, and international markets. The group's largest contributor is Tiger Balm, arguably the world's leading topical analgesic...
What is Haw Par Corporation Limited's Cyborg Score?+
Haw Par Corporation Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Haw Par Corporation Limited's main competitors?+
Named competitors include Pain Relief Products, Regional Topical Analgesics. The full competitive landscape is in the AskCyborg report.
How can I get the full Haw Par Corporation Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Haw Par Corporation Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Haw Par Corporation Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Consumer Healthcare research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Perrigo